← All candidates
One insider bought $20.0K in a single day.
1 filing on record.
TLXTelix Pharmaceuticals Ltd
NasdaqGS · Healthcare · $4.41B
$11.78
+8.91% · Sep 15
One insider bought $20.0K in a single day.
Led by Smith Darren Charlton, group chief financial officer.
Price · 1Y · daily● 1 buy
▸ hover a marker for the filing · drag to zoom · daily bars sharpen to 30-min on close ranges · 2 moves explained
AI brief · from the filings on this pagePro
The filings, the score and the setup on this page, read for you in about ten seconds — what the insiders did, and what stands against it.
Market cap
$4.41B
Float
273.6M
81% public
Short % float
Pro
Price / profit
129.9
Price / future profit
89.2
Price / sales
5.0
The buyers
▸ each insider's past open-market buys, measured ~6 months (120 trading days) later, against the S&P over the same spans · split-adjusted · pre-scheduled 10b5-1 plan trades excluded · past outcomes, not predictions
Group Chief Financial Officer
Smith Darren Charlton
Bought $20.0K on Sep 7 — 2,071 sh @ $9.66, held direct, 15% of their stake.
First Form 4 on file
The record
newest first
DateTypeInsiderOf stakeShares @ priceValue
Context
Wall St
$21.32 avg target
+81.0% vs today · 3 analysts · consensus Strong Buy
▸ relayed analyst opinion, which tends to run optimistic — not our forecast or advice
Coverage
TLX Stock Clocks 5% Gain This Week Ahead Of FDA Decision On Brain Cancer Imaging AgentStocktwits · 1w agoTelix Pharmaceuticals Shares Rise 5.3% as Analyst Highlights BiPASS Trial and FDA PathwayInvestorsHub · 1w agoTelix Pharmaceuticals Stock Leads 3 Fast Growing Insider Owned SharesSimply Wall St. · 2w agoTelix Pharmaceuticals Limited Q2 2026 Earnings Call SummaryMoby · 3w ago
The file stays open
1 filing on record.
The next one will be too.
▸ SEC EDGAR · FINRA · Nasdaq — public sources only · research, not advice